Search Results for "data"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for data. Results 701 to 710 of 1106 total matches.

Drugs for Depression

   
The Medical Letter on Drugs and Therapeutics • Dec 11, 2023  (Issue 1691)
) has the most data supporting its efficacy and safety for this indication.10,11 A fixed-dose combination ...
A selective serotonin reuptake inhibitor (SSRI) is generally used for initial treatment of major depressive disorder (MDD). A serotonin-norepinephrine reuptake inhibitor (SNRI), bupropion (Wellbutrin SR, and others), and mirtazapine (Remeron, and others) are reasonable alternatives. Improvement in symptoms can occur within the first two weeks of treatment with these drugs, but a substantial benefit may not be achieved for 4-8 weeks.
Med Lett Drugs Ther. 2023 Dec 11;65(1691):193-200   doi:10.58347/tml.2023.1691a |  Show IntroductionHide Introduction

Mesalamine For Ulcerative Colitis

   
The Medical Letter on Drugs and Therapeutics • May 20, 1988  (Issue 766)
4-gram (60 ml) enema per day, preferably at bedtime to improve retention. Preliminary data suggest ...
Mesalamine (Rowasa - Reid-Rowell), probably better known as 5-aminosalicylic acid (5-ASA) and also called mesalazine in some other countries, was recently marketed in the USA as an enema for treatment of mild to moderate distal ulcerative colitis, including ulcerative proctosigmoiditis and ulcerative proctitis.
Med Lett Drugs Ther. 1988 May 20;30(766):53-4 |  Show IntroductionHide Introduction

Mupirocin - A New Topical Antibiotic

   
The Medical Letter on Drugs and Therapeutics • May 20, 1988  (Issue 766)
Available data suggest that it could be more effective than other topical antibiotics and as effective ...
Mupirocin (Bactroban - Beecham), a topical antibiotic formerly called pseudomonic acid, was recently approved by the US Food and Drug Administration for treatment of impetigo. It will be sold as a 2% ointment available only by prescription.
Med Lett Drugs Ther. 1988 May 20;30(766):55-6 |  Show IntroductionHide Introduction

Erythropoietin For Anemia

   
The Medical Letter on Drugs and Therapeutics • Sep 22, 1989  (Issue 801)
respond to the drug, but more data are needed. THE MEDICAL LETTER (ISSN 1523-2859) is published ...
Production of erythropoietin, a glycoprotein hormone secreted mainly by the kidney, is often low in patients with chronic renal failure (JW Eschbach, Kidney Int, 35:134, 1989). The US Food and Drug Administration recently approved marketing of epoetin alfa (Epogen - Amgen), a recombinant human erythropoietin, for treatment of anemia in such patients. Epoetin is commercially available in Europe as Eprex (Ortho), and Eprex is available from Ortho in the USA on an investigational basis for treatment of anemia related to AIDS. Epogen and Eprex are chemically...
Med Lett Drugs Ther. 1989 Sep 22;31(801):85-6 |  Show IntroductionHide Introduction

Felbamate

   
The Medical Letter on Drugs and Therapeutics • Nov 26, 1993  (Issue 910)
, 1991), but valproate, according to felbamate’s manufacturer, does not. Few data are available ...
Felbamate (Felbatol - Wallace Laboratories), a phenyl dicarbamate structurally similar to meprobamate (Equanil, and others), was recently approved by the US Food and Drug Administration for use alone or with other drugs in adults with partial seizures with or without secondary generalization. It was also approved for use in addition to other drugs in children with the multiple types of seizures associated with the Lennox-Gastaut syndrome, a severe epileptic encephalopathy.
Med Lett Drugs Ther. 1993 Nov 26;35(910):107-8 |  Show IntroductionHide Introduction

Nefazodone for Depression

   
The Medical Letter on Drugs and Therapeutics • Apr 14, 1995  (Issue 946)
may be 50 to 200 mg b.i.d. CONCLUSION — Available data are inadequate to determine how nefazodone compares ...
Nefazodone (Serzone - Bristol-Myers Squibb) was recently approved by the US Food and Drug Administration for treatment of depression. A phenylpiperazine, nefazodone is chemically related to trazodone (Desyrel, and others).
Med Lett Drugs Ther. 1995 Apr 14;37(946):33-5 |  Show IntroductionHide Introduction

Varicella Vaccine

   
The Medical Letter on Drugs and Therapeutics • Jun 23, 1995  (Issue 951)
simultaneously with measles-mumps-rubella (MMR) vaccine, using separate syringes and injection sites. No data ...
A live attenuated varicella vaccine (Varivax - Merck) has been approved for marketing by the US Food and Drug Administration. The Oka/Merck strain used in the vaccine is attenuated by passage in human and embryonic guinea pig cell cultures.
Med Lett Drugs Ther. 1995 Jun 23;37(951):55-7 |  Show IntroductionHide Introduction

Echinacea for Prevention and Treatment of Upper Respiratory Infections

   
The Medical Letter on Drugs and Therapeutics • Apr 01, 2002  (Issue 1127)
they felt better. One study did not use standardized dosage or record data, but relied on the subjects ...
Echinacea, a plant also called purple coneflower, is widely used as a dietary supplement for prevention and treatment of colds.
Med Lett Drugs Ther. 2002 Apr 1;44(1127):29-30 |  Show IntroductionHide Introduction

Fulvestrant (Faslodex) for Advanced Breast Cancer

   
The Medical Letter on Drugs and Therapeutics • Jul 22, 2002  (Issue 1135)
with combined data and updated results found a longer duration of response with fulvestrant, 16.7 vs. 13.6 ...
Fulvestrant (Faslodex -- AstraZeneca), an estrogen receptor antagonist given intramuscularly (IM) once a month, was recently approved by the FDA for treatment of hormone-receptor-positive metastatic breast cancer in postmenopausal women with disease progession on tamoxifen (Nolvadex, and others) or another antiestrogen.
Med Lett Drugs Ther. 2002 Jul 22;44(1135):65-6 |  Show IntroductionHide Introduction

Alefacept (Amevive) For Treatment of Psoriasis

   
The Medical Letter on Drugs and Therapeutics • Apr 14, 2003  (Issue 1154)
for more than a year, but the data are still incomplete (GG Krueger et al, J Am Acad Dermatol 2002; 47:821 ...
Alefacept (a le' fa sept; Amevive - Biogen) has been approved by the FDA for parenteral treatment of adults with moderate to severe chronic plaque psoriasis.
Med Lett Drugs Ther. 2003 Apr 14;45(1154):31-2 |  Show IntroductionHide Introduction